Robert F. Werner, an officer of Twist Bioscience Corp, filed a Form 144 notice on November 16, 2026, proposing the sale of 1,637 shares of common stock on NASDAQ.

Key Highlights

  • Proposed sale: 1,637 shares of Twist Bioscience Corp common stock, with an aggregate market value of $169,737.91, according to the filing.
  • Source of shares: The shares were acquired on November 12, 2026, through restricted stock vesting from the issuer, classified as compensation.
  • Tax-related purpose: The filing states the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution."
  • Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917, is named as the broker for the proposed sale.
  • Shares outstanding: The filing reports 62,707,424 shares of common stock outstanding at the approximate date of sale.
  • Prior three-month sales: Werner sold a total of 3,391 shares in five separate transactions between August 21, 2026, and November 3, 2026, generating gross proceeds of $542,404.87 in aggregate.

Werner's Proposed Share Sale at Twist Bioscience: Filing Details

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission on November 16, 2026, Robert F. Werner, identified as an officer of Twist Bioscience Corp (NASDAQ:TWST), intends to sell 1,637 shares of the company's common stock. The aggregate market value of the proposed sale is listed as $169,737.91. The approximate date of sale is November 16, 2026, and the sale is to be executed on NASDAQ through Fidelity Brokerage Services LLC.

The filing discloses that the 1,637 shares were acquired on November 12, 2026, via restricted stock vesting from the issuer, with the nature of payment listed as compensation. A remark in the filing states that the sale is intended to cover a tax obligation arising from the settlement of a vested equity award distribution. Twist Bioscience Corp is headquartered at 681 Gateway Blvd., South San Francisco, California 94080, and its SEC file number is listed as 001-38720.

The filing also details Werner's prior sales of Twist Bioscience common stock during the three months preceding the notice. Those transactions occurred on August 21, 2026 (669 shares, $93,035.42), August 24, 2026 (854 shares, $120,219.72), September 8, 2026 (238 shares, $29,184.49), October 2, 2026 (1,482 shares, $279,925.79), and November 3, 2026 (148 shares, $20,039.45). Combined, these five sales totaled 3,391 shares and $542,404.87 in gross proceeds, as reported in the filing.

What Was Disclosed

Twist Bioscience officer Robert F. Werner filed a Form 144 notice proposing to sell 1,637 shares of common stock valued at $169,737.91, acquired through restricted stock vesting on November 12, 2026, with the stated purpose of covering a tax obligation from an equity award settlement.